Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Filter:

Collection: Choice of COVID-19 Vaccines

2 Results

Commentary
When is it reasonable to extrapolate during a pandemic?: The case of broad UK labeling for AstraZeneca COVID-19 vaccine
European Journal of Internal Medicine
Vol. 87p1–2Published online: March 18, 2021
- Rafael Dal-Ré
- Rita Banzi
Cited in Scopus: 2
Amid an unprecedented surge of COVID-19 cases in the UK, with an increasing number due to a novel more infectious SARS-CoV-2 variant,[1] the UK regulatory agency (MHRA) granted emergency approval to the AstraZeneca COVID-19 vaccine on 30 December 2020. The target population includes adults and elderly. The posology consisting of two separate doses given 4-12 weeks apart. Almost simultaneously, the UK health authorities recommended a dose interval of 12 weeks for both COVID-19 authorized vaccines (Pfizer/BioNTech; AstraZeneca), due to the shortage of doses and to vaccinate the highest number of citizens.
Letter to the Editor
“Let me choose my COVID-19 vaccine”
European Journal of Internal Medicine
Vol. 87p104–105Published online: February 3, 2021
- Rafael Dal-Ré
- Richard Stephens
- Nadarajah Sreeharan
Cited in Scopus: 13
In the first half of 2021, many millions of Europeans will be offered vaccination against SARS -CoV-2. Four vaccines, two mRNA-based vaccines (Pfizer-BioNTech and NIH-Moderna) and two non-replicating viral vector-based vaccines (Oxford-AstraZeneca and Janssen) will likely be available through national health services (NHS). Should citizens accept the vaccine provided by their NHS or should they have the option of selecting the vaccine of their choice?

Filter:

Filters applied

Article Type

Publication Date

Author

Journal

Keyword

Access Filter

Collection: Choice of COVID-19 Vaccines

When is it reasonable to extrapolate during a pandemic?: The case of broad UK labeling for AstraZeneca COVID-19 vaccine

“Let me choose my COVID-19 vaccine”